Positives

• Rybelsus may interest some Long COVID or ME/CFS patients because semaglutide and other GLP-1 medications are being explored informally for metabolic inflammation, blood-sugar swings, and appetite regulation (WebMD).
• The oral form avoids injections, which may matter for patients who are needle-averse or already overwhelmed by complex treatment routines (Mayo Clinic).

Negatives

• Patient reviews mostly focus on diabetes, appetite, nausea, and weight effects rather than improvements in Long COVID, ME/CFS, Lyme, POTS, MCAS, or chronic fatigue symptoms (WebMD).
• Nausea, constipation, diarrhea, appetite suppression, and delayed stomach emptying may worsen existing GI problems or make under-fueling more likely (Mayo Clinic).

Hurdles & Side Effects

• Rybelsus must be taken with a strict empty-stomach routine, which can be hard for patients with morning nausea, medication timing issues, or unstable symptoms (Drugs.com).
• Insurance coverage usually follows diabetes indications, so off-label use for chronic illness symptoms may be difficult to access (Mayo Clinic).